About Ventinova

We are able to develop ideas and solutions that surprise the medical field.

Founded in 2013, with extensive medical experience, Ventinova Medical is a company that develops and markets innovative products for airway management and patient ventilation.

We believe in creating a new ventilation concept through revolutionary products. Products that are more than just upgrades of current standard practice.

With our knowledge and access to state-of-the-art technology we are able to develop ideas and solutions that surprise the medical field. The philosophy behind all our products is active expiration or expiration by suction.

Inventions and Innovations

The credit for inventing the concept behind our mechanical ventilator, Evone, and manual ventilator, Ventrain, goes to Prof. Dr. D. Enk, MD.

Specializing in airway management for more than twenty years, Prof. Enk fully committed himself to the research on a flow-controlled ventilator, allowing safe and efficient ventilation of patients through a ‘straw’, even in the case of airway obstruction.

His initial idea has been further developed in close collaboration between Ventinova Medical and Prof. Enk’s clinical research group.

Ventinova Medical develops and markets innovative medical devices.

«La energía disipada es mínima con esta tecnología FCV»

Prof. emer. Tom Barnes
Fellow of the Institute of Physics, London, UK

«Tritube me facilita mucho el trabajo en vía aérea difícil.»

Dr. Hans Mahieu
Med. Laringólogo, Hospital Meander Amersfoort

» La tecnología FCV mantiene el acceso al pulmon de forma suave»

Dr. med. Dietmar Enk
Inventor/Anesthesiologist/Intensivist, University Münster,

Close collaboration

Ventinova Medical develops and markets innovative medical devices. The products that are currently on the market are: mechanical ventilator, Evone; manual ventilator, Ventrain; the ultrathin tube, Tritube; and 2 mm transtracheal catheter, Cricath.

We believe that diversity is the strength of our team. It consists of experts in research, development and marketing, production and regulatory affairs.

The development of Ventrain is enabled with contribution from The European Regional Development Fund in the framework of OP-Zuid and the Dutch government.

For the development of Evone, Ventinova Medical has received funding from the European Union’s Horizon 2020 Research and Innovation Programme and Innovation Credit from the Dutch Ministry of Economic Affairs and Climate Policy.